A2M

1.96%

$6.77 the a2 milk company limited

Agree. The more copycats meaning more companies agree that a2/a2...

First 46 Last

Share
Profile

Follow
lhantian

47 Posts.

27

30/03/18

22:09

Post #: 32146183
Share

Originally posted by happydays2018 ↑

I’m not a regular poster here, you can call me a newbie, but I would like to post my own thoughts on the current free fall of A2M’s SP.

I’ve taken interest in A2M stock for quite a number of months now. Having thoroughly researched A2M I’ve finally decided to invest in A2M, as I strongly believe that they are truly a great business with solid financials. Most importantly they are a company that has grown exponentially and continues to have very good growth prospects for the future and many years to come.

I think A2M has strategically aligned and well positioned itself for both competition and advancements with its deal with Fonterra, along with its expansion into new markets such as the US, and the launching of its new products such as pregnancy formula in 2H18.

A2M’s success in IF is partially or if not mostly due to the influence of Daigous and is dependent on the Daigou channel to maintain and increase it’s revenue stream in regards to IF. Like many posters have already mentioned already, A2M offers product differentiation and is purchased by mums who don’t mind to pay a premium price in return for its purity, quality and reputation. If not for this point, many daigous cannot make a living out of it, can they?

I have friends who are daigous, and the top brands that they are selling and have sold for than extensive period of time is A2M, which is constantly out of stock and their customers are loyal and place orders in advance to ensure they get it. It is then followed by Bellamy’s then Aptamil, they simply don’t promote any of the Nestle brands as it’s not in demand as the above mentioned.

As such, I personally don’t see Wyeth Atwo formula is much of a threat, but just another additional IF made available to the market in CHINA, not NZ/AUSTRALIA. If it was the other way around it would be a different story.

People are entitled to their opinions and this is mine. I’m not here to encourage people to buy or sell their shares as that is a decision for themselves to make. I’m just stating the reality of the daigou business and how it makes continuous and significant contribution to the A2M brand for those who do not realise the importance of it.

The market is always susceptible to volatility and there are bound to be ups and downs whether due to macro or industry related factors. It certainly is not a P&D stock. So I’d say just to sit back enjoy the ride for medium to LT holders. I, as many holders here have faith in this company.

GLTA & have a wonderful Easter holiday.

Expand

Agree.
The more copycats meaning more companies agree that a2/a2 is a much better products. More free promotions and news to encourage and increase awareness of a2/a2 benefits. More consumers convert to a2/a2 products consumers not just for the IF but also the adult milk powder and fresh milk.
But remember consumers are not stupid, they know who is the real a2/a2 (a2mc) and who are the copycats.
DYOR and GLTA.

Last edited by lhantian: 30/03/18

A2M Price at posting: $11.46 Sentiment: Buy Disclosure: Held
8 Upvote

1 Great analysis

Reply

Top Stories

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Microcap Wrap: 5 explorers with news out today

RCE

Recce's R327 found effective against E.coli during clinical trial

There are more pages in this discussion • 104 more messages in this thread...

First 46 Last

Add A2M (ASX) to my watchlist

(20min delay)
Last $6.77		Change 0.130(1.96%)		Mkt cap ! $4.894B

Open	High	Low	Value	Volume
$6.63	$6.77	$6.63	$10.00M	1.485M

Buyers (Bids)

No.	Vol.	Price($)
1	2420	$6.76

Sellers (Offers)

Price($)	Vol.	No.
$6.77	37726	4

View Market Depth

No.	Vol.	Price($)
1	1000	6.740
2	700	6.700
1	5009	6.680
1	12000	6.650
1	1130	6.640

Price($)	Vol.	No.
6.770	18339	2
6.780	500	1
6.790	3000	2
6.800	6054	6
6.810	600	1

Last trade - 16.10pm 28/06/2024 (20 minute delay)

A2M (ASX) Chart

Agree. The more copycats meaning more companies agree that a2/a2...

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Ava Risk Group expands US presence with A$0.7M Substation Deal

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Silver Mines models five new calderas close to 396Moz Bowdens deposit

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Microcap Wrap: 5 explorers with news out today

Recce's R327 found effective against E.coli during clinical trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Agree. The more copycats meaning more companies agree that a2/a2...

Top Stories

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Ava Risk Group expands US presence with A$0.7M Substation Deal

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Silver Mines models five new calderas close to 396Moz Bowdens deposit

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Microcap Wrap: 5 explorers with news out today

Recce's R327 found effective against E.coli during clinical trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News